FDA says that surgical mesh used for transvaginal repair of pelvic organ prolapse should be regulated under tougher standards based health risks associated with the devices.
Under proposals issued by the agency on April 29, FDA would reclassify
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?